Viusid/Alzer efficacy in the treatment of Parkinson’s disease associated fatigue



Document title: Viusid/Alzer efficacy in the treatment of Parkinson’s disease associated fatigue
Journal: Belize journal of medicine
Database: PERIÓDICA
System number: 000418447
ISSN: 2225-8116
Authors: 1
2
1
1
1
1
1
1
1
1
1
1
1
1
1
Institutions: 1Hospital "Salvador Allende", La Habana. Cuba
2Instituto de Gastroenterología, La Habana. Cuba
Year:
Season: Jun
Volumen: 1
Number: 3
Pages: 14-19
Country: Belice
Language: Inglés
Document type: Artículo
Approach: Experimental, caso clínico
English abstract Fatigue is a very frequent symptom among patients with Parkinson’s disease (PD) for which there is no effective treatment. In clinical studies of patients with viral and liver diseases, fatigue improvement has been demonstrated with the used of Viusid and Alzer. METHODS. A randomized, double blind and placebo controlled clinical trial was carried out in 100 patients, 50 in each group, from October 2009 to May 2011. Group A or the study group, received combined Viusid and Alzer treatment and group B or the control group, placebo. RESULTS. At 3 months in the study group only 2 showed fatigue (4%), which was maintained at six months and one year, with significant differences when compared to the control group. There was also improvement in fatigue severity, evaluated by PFS. CONCLUSIONS. The combined use of Viusid/Alzer nutritional supplements is effective in PD patient treatment, therefore it should be evaluated in studies with larger number of patients and a methodology that supports this indication
Disciplines: Medicina
Keyword: Neurología,
Terapéutica y rehabilitación,
Enfermedad de Parkinson,
Fatiga,
Viusid,
Alzer,
Síntomas
Keyword: Neurology,
Therapeutics and rehabilitation,
Parkinson disease,
Fatigue,
Viusid,
Alzer,
Symptoms
Full text: Texto completo (Ver PDF)